World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
23429
World Ranking
18004
National Ranking
95

Harald Arnesen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Harald Arnesen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 481 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Harald Arnesen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Harald Arnesen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Harald Arnesen is affiliated with Oslo University Hospital in Norway, contributing substantially to the field of medicine with a focus on cardiology and cardiovascular research. Their scholarly output includes 101 published works in medicine, with notable specialization across several subfields, including cardiology and cardiovascular medicine (45 publications), immunology (16), physiology (14), molecular biology (12), and surgery (10).

Their research topics cover a range of areas related to cardiovascular health and disease mechanisms. These include fatty acid research and health, cardiovascular disease and adiposity, atrial fibrillation management and outcomes, eicosanoids and hypertension pharmacology, the complement system in diseases, neutrophil, myeloperoxidase and oxidative mechanisms, and acute myocardial infarction research.

Harald Arnesen's work has appeared frequently in prominent journals and venues such as European Heart Journal (11 publications), Circulation (4), Tidsskrift for Den norske legeforening (4), Atherosclerosis (3), and Nutrients (2).

Noteworthy recent papers include:

  • Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction, 2020, Circulation
  • P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events, 2023, Journal of the American College of Cardiology
  • Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction, 2020, Scientific Reports
  • Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial, 2022, Journal of Internal Medicine
  • Biomarkers of ageing and cardiac remodeling are associated with atrial fibrillation, 2021, Scandinavian Cardiovascular Journal

The scientist has collaborated extensively with a core group of frequent co-authors, including Ingebjørg Seljeflot (50 joint works), Svein Solheim (34), Peder L. Myhre (18), Ragnhild Helseth (18), and Are A. Kalstad (15).

Best Publications

  • Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

    Ketil Lunde;Svein Solheim;Svend Aakhus;Harald Arnesen

  • Warfarin, aspirin, or both after myocardial infarction☆

    M. Hurlen;M. Abdelnoor;P. Smith;J. Erikssen

  • The effect of warfarin on mortality and reinfarction after myocardial infarction.

    Pål Smith;Harald Arnesen;Ingar Holme

  • Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.

    Raffaele De Caterina;Steen Husted;Lars Wallentin;Felicita Andreotti

  • Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology.

    P. G. Steg;K. Huber;F. Andreotti;H. Arnesen

  • Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

    G. Y. H. Lip;K. Huber;F. Andreotti;H. Arnesen

  • Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)

    Dahl Oe;Andreassen G;Aspelin T;Müller C

  • Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency.

    Jan Eritsland;Harald Arnesen;Knut Grønseth;Nils B. Fjeld

  • Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).

    Else Høibraaten;Erik Qvigstad;Harald Arnesen;Stig Larsen

  • New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper

    Raffaele De Caterina;Steen Husted;Lars Wallentin;Felicita Andreotti

  • Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances: Results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction)

    Ellen Bøhmer;Pavel Hoffmann;Michael Abdelnoor;Harald Arnesen

  • Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study.

    Harald Arnesen;Arne Høiseth;Bernt Ly

  • Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.

    Kjell Andersen;Mette Hurlen;Harald Arnesen;Ingebjørg Seljeflot

  • Antiplatelet agents for the treatment and prevention of atherothrombosis

    Carlo Patrono;Felicita Andreotti;Harald Arnesen;Lina Badimon

  • Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology

    Wiktor Kuliczkowski;Adam Witkowski;Lech Polonski;Cezary Watala

  • Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary—a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

    Gregory Y.H. Lip;Kurt Huber;Felicita Andreotti;Harald Arnesen

  • Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.

    Are Annesønn Kalstad;Are Annesønn Kalstad;Peder Langeland Myhre;Peder Langeland Myhre;Kristian Laake;Sjur Hansen Tveit;Sjur Hansen Tveit

  • The Effect of Supplementation With Omega-3 Fatty Acids on Soluble Markers of Endothelial Function in Patients With Coronary Heart Disease

    Odd Johansen;Ingebjørg Seljeflot;Arne T. Høstmark;Harald Arnesen

  • General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

    R De Caterina;S Husted;Lars Wallentin;F Andreotti

  • High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors — a 28-30 years follow-up study:

    Jostein Grimsmo;Irene Grundvold;Sverre Maehlum;Harald Arnesen

Frequent Co-Authors

Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Kurt Huber
Kurt Huber Sigmund Freud University Vienna
Peter Kierulf
Peter Kierulf Oslo University Hospital
Per Andersen
Per Andersen University of Copenhagen
Gregory Y.H. Lip
Gregory Y.H. Lip University of Liverpool
Steen Dalby Kristensen
Steen Dalby Kristensen Aarhus University Hospital
Agneta Siegbahn
Agneta Siegbahn Uppsala University
Raffaele De Caterina
Raffaele De Caterina University of Pisa
Jeffrey I. Weitz
Jeffrey I. Weitz McMaster University
Lina Badimon
Lina Badimon Hospital de la Santa Creu i Sant Pau

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine often involves more than just a traditional MD. There are many related pathways you can consider that offer flexibility and unique career opportunities.

Nursing is a popular choice for those wanting to work in patient care, and entry requirements may surprise you. For instance, do you have to take the teas test to get into nursing school? Not all programs require this, so researching your options is essential.

Another fast-growing field is healthcare management. Healthcare administration degree programs can be completed online and lead to administrative and leadership roles in hospitals and clinics. These roles focus more on operations than direct patient care.

Many registered nurses consider advanced practice roles. ASN to NP programs allow RNs to bridge quickly toward a master's degree and become nurse practitioners, opening doors to autonomous practice and higher salaries.

If you’re passionate about nutrition and wellness, an online dietitian degree can prepare you for a rewarding career helping others improve their health. Online options make it easier for busy students to balance study and life.

Best Scientists Citing Harald Arnesen

Trending Scientists

Recently Published Articles